{
  "DOI": "10.1007/s00439-017-1803-x",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-017-1803-x",
  "alternative-id": [
    "1803"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kozlovski",
      "given": "Itamar",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Siegfried",
      "given": "Zahava",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Amar-Schwartz",
      "given": "Adi",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7552-9617",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Karni",
      "given": "Rotem",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ],
    "date-time": "2017-04-20T08:28:43Z",
    "timestamp": 1492676923000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        7,
        27
      ]
    ],
    "date-time": "2022-07-27T18:12:28Z",
    "timestamp": 1658945548000
  },
  "funder": [
    {
      "DOI": "10.13039/100005190",
      "award": [
        "307699"
      ],
      "doi-asserted-by": "publisher",
      "name": "Melanoma Research Alliance"
    },
    {
      "DOI": "10.13039/501100003977",
      "award": [
        "1290/12"
      ],
      "doi-asserted-by": "publisher",
      "name": "Israel Science Foundation"
    },
    {
      "DOI": "10.13039/100001698",
      "award": [
        "Len \u0026 Susan Mark Initiative for Ovarian and Uterine/MMMT Cancers Award"
      ],
      "doi-asserted-by": "publisher",
      "name": "Israel Cancer Research Fund"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        20
      ]
    ],
    "date-time": "2024-04-20T19:18:42Z",
    "timestamp": 1713640722999
  },
  "is-referenced-by-count": 54,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2017,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            4,
            20
          ]
        ],
        "date-time": "2017-04-20T00:00:00Z",
        "timestamp": 1492646400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-017-1803-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-017-1803-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-017-1803-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1113-1127",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/onc.2012.306",
      "author": "L Adesso",
      "doi-asserted-by": "publisher",
      "first-page": "2848",
      "journal-title": "Oncogene",
      "key": "1803_CR1",
      "unstructured": "Adesso L, Calabretta S, Barbagallo F et al (2012) Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Oncogene 32:2848–2857. doi: 10.1038/onc.2012.306",
      "volume": "32",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrc.2016.71",
      "author": "BJ Altman",
      "doi-asserted-by": "publisher",
      "first-page": "619",
      "journal-title": "Nat Rev Cancer",
      "key": "1803_CR2",
      "unstructured": "Altman BJ, Stine ZE, Dang CV (2016) From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer 16:619–634. doi: 10.1038/nrc.2016.71",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1126/science.1211485",
      "author": "D Anastasiou",
      "doi-asserted-by": "publisher",
      "first-page": "1278",
      "journal-title": "Science",
      "key": "1803_CR3",
      "unstructured": "Anastasiou D, Poulogiannis G, Asara JM et al (2011) Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334:1278–1283. doi: 10.1126/science.1211485",
      "volume": "334",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nchembio.1060",
      "author": "D Anastasiou",
      "doi-asserted-by": "publisher",
      "first-page": "839",
      "journal-title": "Nat Chem Biol",
      "key": "1803_CR4",
      "unstructured": "Anastasiou D, Yu Y, Israelsen WJ et al (2012) Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 8:839–847. doi: 10.1038/nchembio.1060",
      "volume": "8",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nsmb.2207",
      "author": "O Anczuków",
      "doi-asserted-by": "publisher",
      "first-page": "220",
      "journal-title": "Nat Struct Mol Biol",
      "key": "1803_CR5",
      "unstructured": "Anczuków O, Rosenberg AZ, Akerman M et al (2012) The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 19:220–228. doi: 10.1038/nsmb.2207",
      "volume": "19",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0116929",
      "author": "S Araki",
      "doi-asserted-by": "publisher",
      "first-page": "e0116929",
      "journal-title": "PLoS ONE",
      "key": "1803_CR6",
      "unstructured": "Araki S, Dairiki R, Nakayama Y et al (2015) Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing. PLoS ONE 10:e0116929. doi: 10.1371/journal.pone.0116929",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.2337/diabetes.52.9.2426",
      "author": "A Asipu",
      "doi-asserted-by": "publisher",
      "first-page": "2426",
      "journal-title": "Diabetes",
      "key": "1803_CR7",
      "unstructured": "Asipu A, Hayward BE, O’Reilly J, Bonthron DT (2003) Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes 52:2426–2432. doi: 10.2337/diabetes.52.9.2426",
      "volume": "52",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.cmet.2013.04.013",
      "author": "I Babic",
      "doi-asserted-by": "publisher",
      "first-page": "1000",
      "journal-title": "Cell Metab",
      "key": "1803_CR8",
      "unstructured": "Babic I, Anderson ES, Tanaka K et al (2013) EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metab 17:1000–1008. doi: 10.1016/j.cmet.2013.04.013",
      "volume": "17",
      "year": "2013"
    },
    {
      "DOI": "10.1002/path.2496",
      "author": "EY Baitei",
      "doi-asserted-by": "publisher",
      "first-page": "707",
      "journal-title": "J Pathol",
      "key": "1803_CR9",
      "unstructured": "Baitei EY, Zou M, Al-Mohanna F et al (2009) Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma. J Pathol 217:707–715. doi: 10.1002/path.2496",
      "volume": "217",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.celrep.2012.11.020",
      "author": "V Ben-Hur",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Cell Rep",
      "key": "1803_CR10",
      "unstructured": "Ben-Hur V, Denichenko P, Siegfried Z et al (2013) S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1. Cell Rep 3:103–115. doi: 10.1016/j.celrep.2012.11.020",
      "volume": "3",
      "year": "2013"
    },
    {
      "DOI": "10.1146/annurev-pharmtox-010716-104846",
      "author": "CF Bennett",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Annu Rev Pharmacol Toxicol",
      "key": "1803_CR11",
      "unstructured": "Bennett CF, Baker BF, Pham N et al (2017) Pharmacology of antisense drugs. Annu Rev Pharmacol Toxicol 5715:1–25. doi: 10.1146/annurev-pharmtox-010716-104846",
      "volume": "5715",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S0092-8674(00)00122-7",
      "author": "M Bienz",
      "doi-asserted-by": "publisher",
      "first-page": "311",
      "journal-title": "Cell",
      "key": "1803_CR12",
      "unstructured": "Bienz M, Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103:311–320. doi: 10.1016/S0092-8674(00)00122-7",
      "volume": "103",
      "year": "2000"
    },
    {
      "DOI": "10.1038/nsmb1020",
      "author": "M Blaustein",
      "doi-asserted-by": "publisher",
      "first-page": "1037",
      "journal-title": "Nat Struct Mol Biol",
      "key": "1803_CR13",
      "unstructured": "Blaustein M, Pelisch F, Tanos T et al (2005) Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 12:1037–1044. doi: 10.1038/nsmb1020",
      "volume": "12",
      "year": "2005"
    },
    {
      "DOI": "10.18632/oncotarget.278",
      "author": "K Bluemlein",
      "doi-asserted-by": "publisher",
      "first-page": "393",
      "journal-title": "Oncotarget",
      "key": "1803_CR14",
      "unstructured": "Bluemlein K, Grüning N-M, Feichtinger RG et al (2011) No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2:393–400. doi: 10.18632/oncotarget.278",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrd3823",
      "author": "S Bonnal",
      "doi-asserted-by": "publisher",
      "first-page": "847",
      "journal-title": "Nat Rev Drug Discov",
      "key": "1803_CR15",
      "unstructured": "Bonnal S, Vigevani L, Valcárcel J (2012) The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov 11:847–859. doi: 10.1038/nrd3823",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1200/jco.2002.20.2.379",
      "author": "R Bos",
      "doi-asserted-by": "publisher",
      "first-page": "379",
      "journal-title": "J Clin Oncol",
      "key": "1803_CR16",
      "unstructured": "Bos R, van Der Hoeven JJM, van Der Wall E et al (2002) Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 20:379–387. doi: 10.1200/jco.2002.20.2.379",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.12192669",
      "author": "HF Bunn",
      "doi-asserted-by": "publisher",
      "first-page": "222",
      "journal-title": "Science",
      "key": "1803_CR17",
      "unstructured": "Bunn HF, Higgins PJ (1981) Reaction of monosaccharides with proteins: possible evolutionary significance. Science 213:222–224. doi: 10.1126/science.12192669",
      "volume": "213",
      "year": "1981"
    },
    {
      "DOI": "10.1038/sj/neo/7900147",
      "author": "BM Burt",
      "doi-asserted-by": "publisher",
      "first-page": "189",
      "journal-title": "Neoplasia",
      "key": "1803_CR18",
      "unstructured": "Burt BM, Humm JL, Kooby DA et al (2001) Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia 3:189–195. doi: 10.1038/sj/neo/7900147",
      "volume": "3",
      "year": "2001"
    },
    {
      "DOI": "10.1038/onc.2015.270",
      "author": "S Calabretta",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Oncogene",
      "key": "1803_CR19",
      "unstructured": "Calabretta S, Bielli P, Passacantilli I et al (2015) Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells. Oncogene 35:1–9. doi: 10.1038/onc.2015.270",
      "volume": "35",
      "year": "2015"
    },
    {
      "DOI": "10.1158/2159-8290.CD-12-0345",
      "author": "JR Cantor",
      "doi-asserted-by": "publisher",
      "first-page": "881",
      "journal-title": "Cancer Discov",
      "key": "1803_CR20",
      "unstructured": "Cantor JR, Sabatini DM (2012) Cancer cell metabolism: one hallmark, many faces. Cancer Discov 2:881–898. doi: 10.1158/2159-8290.CD-12-0345",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrg775",
      "author": "L Cartegni",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nat Rev Genet",
      "key": "1803_CR21",
      "unstructured": "Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285–298. doi: 10.1038/nrg775",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.1112495109",
      "author": "A Cassago",
      "doi-asserted-by": "publisher",
      "first-page": "1092",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR22",
      "unstructured": "Cassago A, Ferreira AP, Ferreira IM et al (2012) Mitochondrial localization and structure-based phosphate activation mechanism of glutaminase C with implications for cancer metabolism. Proc Natl Acad Sci 109:1092–1097. doi: 10.1073/pnas.1112495109",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature11540",
      "author": "B Chaneton",
      "doi-asserted-by": "publisher",
      "first-page": "458",
      "journal-title": "Nature",
      "key": "1803_CR23",
      "unstructured": "Chaneton B, Hillmann P, Zheng L et al (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491:458–462. doi: 10.1038/nature11540",
      "volume": "491",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nsmb.2219",
      "author": "M Chen",
      "doi-asserted-by": "publisher",
      "first-page": "346",
      "journal-title": "Nat Struct Mol Biol",
      "key": "1803_CR24",
      "unstructured": "Chen M, David CJ, Manley JL (2012) Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins. Nat Struct Mol Biol 19:346–354. doi: 10.1038/nsmb.2219",
      "volume": "19",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.1251033",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1251033",
      "journal-title": "Science",
      "key": "1803_CR25",
      "unstructured": "Chen L, Kostadima M, Martens JHA et al (2014) Transcriptional diversity during lineage commitment of human blood progenitors. Science 345:1251033. doi: 10.1126/science.1251033",
      "volume": "345",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ccell.2016.09.006",
      "author": "W Chen",
      "doi-asserted-by": "publisher",
      "first-page": "779",
      "journal-title": "Cancer Cell",
      "key": "1803_CR26",
      "unstructured": "Chen W, Wang Y-Y, Zhao A et al (2016) Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential. Cancer Cell 30:779–791. doi: 10.1016/j.ccell.2016.09.006",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nbt.2285",
      "author": "H Cheong",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "journal-title": "Nat Biotechnol",
      "key": "1803_CR27",
      "unstructured": "Cheong H, Lu C, Lindsten T, Thompson CB (2012) Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol 30:671–678. doi: 10.1038/nbt.2285",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature06734",
      "author": "HR Christofk",
      "doi-asserted-by": "publisher",
      "first-page": "230",
      "journal-title": "Nature",
      "key": "1803_CR28",
      "unstructured": "Christofk HR, Vander Heiden MG, Harris MH et al (2008a) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233. doi: 10.1038/nature06734",
      "volume": "452",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nature06667",
      "author": "HR Christofk",
      "doi-asserted-by": "publisher",
      "first-page": "181",
      "journal-title": "Nature",
      "key": "1803_CR29",
      "unstructured": "Christofk HR, Vander Heiden MG, Wu N et al (2008b) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452:181–186. doi: 10.1038/nature06667",
      "volume": "452",
      "year": "2008"
    },
    {
      "DOI": "10.1002/path.4129",
      "author": "M Cohen-Eliav",
      "doi-asserted-by": "publisher",
      "first-page": "630",
      "journal-title": "J Pathol",
      "key": "1803_CR30",
      "unstructured": "Cohen-Eliav M, Golan-Gerstl R, Siegfried Z et al (2013) The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. J Pathol 229:630–639. doi: 10.1002/path.4129",
      "volume": "229",
      "year": "2013"
    },
    {
      "DOI": "10.1002/j.1460-2075.1996.tb00357.x",
      "author": "K Colwill",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "journal-title": "EMBO J",
      "key": "1803_CR31",
      "unstructured": "Colwill K, Pawson T, Andrews B et al (1996) The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 15:265–275",
      "volume": "15",
      "year": "1996"
    },
    {
      "DOI": "10.1073/pnas.1212780110",
      "author": "M Cortes-Cros",
      "doi-asserted-by": "publisher",
      "first-page": "489",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR32",
      "unstructured": "Cortes-Cros M, Hemmerlin C, Ferretti S et al (2013) M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc Natl Acad Sci 110:489–494. doi: 10.1073/pnas.1212780110",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.1093/nar/gkv210",
      "author": "M Danan-Gotthold",
      "doi-asserted-by": "publisher",
      "first-page": "5130",
      "journal-title": "Nucleic Acids Res",
      "key": "1803_CR33",
      "unstructured": "Danan-Gotthold M, Golan-Gerstl R, Eisenberg E et al (2015) Identification of recurrent regulated alternative splicing events across human solid tumors. Nucleic Acids Res 43:5130–5144. doi: 10.1093/nar/gkv210",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.celrep.2011.12.001",
      "author": "S Das",
      "doi-asserted-by": "publisher",
      "first-page": "110",
      "journal-title": "Cell Rep",
      "key": "1803_CR34",
      "unstructured": "Das S, Anczuków O, Akerman M, Krainer AR (2012) Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Cell Rep 1:110–117. doi: 10.1016/j.celrep.2011.12.001",
      "volume": "1",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature08697",
      "author": "CJ David",
      "doi-asserted-by": "publisher",
      "first-page": "364",
      "journal-title": "Nature",
      "key": "1803_CR35",
      "unstructured": "David CJ, Chen M, Assanah M et al (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463:364–368. doi: 10.1038/nature08697",
      "volume": "463",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.0709747104",
      "author": "RJ DeBerardinis",
      "doi-asserted-by": "publisher",
      "first-page": "19345",
      "journal-title": "PNAS",
      "key": "1803_CR36",
      "unstructured": "DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. PNAS 104:19345–19350. doi: 10.1073/pnas.0709747104",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1369/jhc.2009.953190",
      "author": "CP Diggle",
      "doi-asserted-by": "publisher",
      "first-page": "763",
      "journal-title": "J Hist Cyt",
      "key": "1803_CR37",
      "unstructured": "Diggle CP, Shires M, Leitch D et al (2009) Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. J Hist Cyt 57:763–774. doi: 10.1369/jhc.2009.953190",
      "volume": "57",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nrneurol.2016.180",
      "author": "JJ Dowling",
      "doi-asserted-by": "publisher",
      "first-page": "675",
      "journal-title": "Nat Publ Gr",
      "key": "1803_CR38",
      "unstructured": "Dowling JJ (2016) Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line. Nat Publ Gr 12:675–676. doi: 10.1038/nrneurol.2016.180",
      "volume": "12",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.molcel.2010.06.022",
      "author": "K Düvel",
      "doi-asserted-by": "publisher",
      "first-page": "171",
      "journal-title": "Mol Cell",
      "key": "1803_CR39",
      "unstructured": "Düvel K, Yecies JL, Menon S et al (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171–183. doi: 10.1016/j.molcel.2010.06.022",
      "volume": "39",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s13073-015-0168-9",
      "author": "H Dvinge",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Genome Med",
      "key": "1803_CR40",
      "unstructured": "Dvinge H, Bradley RK (2015) Widespread intron retention diversifies most cancer transcriptomes. Genome Med 7:45. doi: 10.1186/s13073-015-0168-9",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrc.2016.51",
      "author": "H Dvinge",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "journal-title": "Nat Rev Cancer",
      "key": "1803_CR41",
      "unstructured": "Dvinge H, Kim E, Abdel-Wahab O, Bradley RK (2016) RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer 16:413–430. doi: 10.1038/nrc.2016.51",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1152/physiolgenomics.1999.1.2.51",
      "author": "KM Elgadi",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "journal-title": "Physiol Genomics",
      "key": "1803_CR42",
      "unstructured": "Elgadi KM, Meguid RA, Qian M et al (1999) Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1:51–62 (pii:1/2/51)",
      "volume": "1",
      "year": "1999"
    },
    {
      "DOI": "10.1186/gb-2012-13-7-r59",
      "author": "R Elkon",
      "doi-asserted-by": "publisher",
      "first-page": "R59",
      "journal-title": "Genome Biol",
      "key": "1803_CR43",
      "unstructured": "Elkon R, Drost J, van Haaften G et al (2012) E2F mediates enhanced alternative polyadenylation in proliferation. Genome Biol 13:R59. doi: 10.1186/gb-2012-13-7-r59",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.70.6.1775",
      "author": "P Felig",
      "doi-asserted-by": "publisher",
      "first-page": "1775",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR44",
      "unstructured": "Felig P, Wahren J, Räf L (1973) Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci 70:1775–1779. doi: 10.1073/pnas.70.6.1775",
      "volume": "70",
      "year": "1973"
    },
    {
      "DOI": "10.1016/S0140-6736(16)31408-8",
      "author": "RS Finkel",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Lancet",
      "key": "1803_CR45",
      "unstructured": "Finkel RS, Chiriboga CA, Vajsar J et al (2016) Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 6736:2–11. doi: 10.1016/S0140-6736(16)31408-8",
      "volume": "6736",
      "year": "2016"
    },
    {
      "DOI": "10.3892/or.11.5.1085",
      "author": "D-C Fischer",
      "doi-asserted-by": "publisher",
      "first-page": "1085",
      "journal-title": "Oncol Rep",
      "key": "1803_CR46",
      "unstructured": "Fischer D-C, Noack K, Runnebaum I et al (2004) Expression of splicing factors in human ovarian cancer. Oncol Rep 11:1085–1090. doi: 10.3892/or.11.5.1085",
      "volume": "11",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nrc1478",
      "author": "RA Gatenby",
      "doi-asserted-by": "publisher",
      "first-page": "891",
      "journal-title": "Nat Rev Cancer",
      "key": "1803_CR47",
      "unstructured": "Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–899. doi: 10.1038/nrc1478",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.molcel.2005.10.026",
      "author": "C Ghigna",
      "doi-asserted-by": "publisher",
      "first-page": "881",
      "journal-title": "Mol Cell",
      "key": "1803_CR48",
      "unstructured": "Ghigna C, Giordano S, Shen H et al (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20:881–890. doi: 10.1016/j.molcel.2005.10.026",
      "volume": "20",
      "year": "2005"
    },
    {
      "DOI": "10.4161/rna.7.4.12744",
      "author": "C Ghigna",
      "doi-asserted-by": "publisher",
      "first-page": "495",
      "journal-title": "RNA Biol",
      "key": "1803_CR49",
      "unstructured": "Ghigna C, De Toledo M, Bonomi S et al (2014) Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives. RNA Biol 7:495–503. doi: 10.4161/rna.7.4.12744",
      "volume": "7",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1742-4658.2010.07992.x",
      "author": "G Ghosh",
      "doi-asserted-by": "publisher",
      "first-page": "587",
      "journal-title": "FEBS J",
      "key": "1803_CR50",
      "unstructured": "Ghosh G, Adams JA (2011) Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J 278:587–597. doi: 10.1111/j.1742-4658.2010.07992.x",
      "volume": "278",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-10-4410",
      "author": "R Golan-Gerstl",
      "doi-asserted-by": "publisher",
      "first-page": "4464",
      "journal-title": "Cancer Res",
      "key": "1803_CR51",
      "unstructured": "Golan-Gerstl R, Cohen M, Shilo A et al (2011) Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res 71:4464–4472. doi: 10.1158/0008-5472.CAN-10-4410",
      "volume": "71",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.bbagrm.2016.07.009",
      "author": "JT Granados-Riveron",
      "doi-asserted-by": "publisher",
      "first-page": "1245",
      "journal-title": "Biochim Biophys Acta Gene Regul Mech",
      "key": "1803_CR52",
      "unstructured": "Granados-Riveron JT, Aquino-Jarquin G (2016) The complexity of the translation ability of circRNAs. Biochim Biophys Acta Gene Regul Mech 1859:1245–1251. doi: 10.1016/j.bbagrm.2016.07.009",
      "volume": "1859",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ng.1031",
      "author": "TA Graubert",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "Nat Genet",
      "key": "1803_CR53",
      "unstructured": "Graubert TA, Shen D, Ding L et al (2011) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 44:53–57. doi: 10.1038/ng.1031",
      "volume": "44",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.bbapap.2005.09.010",
      "author": "M Hagiwara",
      "doi-asserted-by": "publisher",
      "first-page": "324",
      "journal-title": "Biochim Biophys Acta Proteins Proteomics",
      "key": "1803_CR54",
      "unstructured": "Hagiwara M (2005) Alternative splicing: a new drug target of the post-genome era. Biochim Biophys Acta Proteins Proteomics 1754:324–331. doi: 10.1016/j.bbapap.2005.09.010",
      "volume": "1754",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.cmet.2012.03.015",
      "author": "A Hagiwara",
      "doi-asserted-by": "publisher",
      "first-page": "725",
      "journal-title": "Cell Metab",
      "key": "1803_CR55",
      "unstructured": "Hagiwara A, Cornu M, Cybulski N et al (2012) Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab 15:725–738. doi: 10.1016/j.cmet.2012.03.015",
      "volume": "15",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jmb.2008.07.055",
      "author": "JC Hagopian",
      "doi-asserted-by": "publisher",
      "first-page": "894",
      "journal-title": "J Mol Biol",
      "key": "1803_CR56",
      "unstructured": "Hagopian JC, Ma CT, Meade BR et al (2008) Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1. J Mol Biol 382:894–909. doi: 10.1016/j.jmb.2008.07.055",
      "volume": "382",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s00262-010-0968-0",
      "author": "D Hanahan",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Cell",
      "key": "1803_CR57",
      "unstructured": "Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70. doi: 10.1007/s00262-010-0968-0",
      "volume": "100",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.cell.2011.02.013",
      "author": "D Hanahan",
      "doi-asserted-by": "publisher",
      "first-page": "646",
      "journal-title": "Cell",
      "key": "1803_CR58",
      "unstructured": "Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. doi: 10.1016/j.cell.2011.02.013",
      "volume": "144",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature11993",
      "author": "TB Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "384",
      "journal-title": "Nature",
      "key": "1803_CR59",
      "unstructured": "Hansen TB, Jensen TI, Clausen BH et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495:384–388. doi: 10.1038/nature11993",
      "volume": "495",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrc.2016.77",
      "author": "N Hay",
      "doi-asserted-by": "publisher",
      "first-page": "635",
      "journal-title": "Nat Rev Cancer",
      "key": "1803_CR60",
      "unstructured": "Hay N (2016) Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer 16:635–649. doi: 10.1038/nrc.2016.77",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1046/j.1432-1327.1998.2570085.x",
      "author": "BE Hayward",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Eur J Biochem",
      "key": "1803_CR61",
      "unstructured": "Hayward BE, Bonthron DT (1998) Structure and alternative splicing of the ketohexokinase gene. Eur J Biochem 257:85–91. doi: 10.1046/j.1432-1327.1998.2570085.x",
      "volume": "257",
      "year": "1998"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-03-0439",
      "author": "X He",
      "doi-asserted-by": "publisher",
      "first-page": "4652",
      "journal-title": "Clin Cancer Res",
      "key": "1803_CR62",
      "unstructured": "He X (2004) Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin Cancer Res 10:4652–4660. doi: 10.1158/1078-0432.CCR-03-0439",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1172/JCI69600",
      "author": "CT Hensley",
      "doi-asserted-by": "publisher",
      "first-page": "3678",
      "journal-title": "J Clin Invest",
      "key": "1803_CR63",
      "unstructured": "Hensley CT, Wasti AT, DeBerardinis RJ (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123:3678–3684. doi: 10.1172/JCI69600",
      "volume": "123",
      "year": "2013"
    },
    {
      "author": "T Higashi",
      "first-page": "173",
      "journal-title": "J Nucl Med",
      "key": "1803_CR64",
      "unstructured": "Higashi T, Saga T, Nakamoto Y et al (2002) Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43:173–180",
      "volume": "43",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ijc.28061",
      "author": "B Hirschi",
      "doi-asserted-by": "publisher",
      "first-page": "590",
      "journal-title": "Int J Cancer",
      "key": "1803_CR65",
      "unstructured": "Hirschi B, Kolligs FT (2013) Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer. Int J Cancer 133:590–596. doi: 10.1002/ijc.28061",
      "volume": "133",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature14985",
      "author": "TY-T Hsu",
      "doi-asserted-by": "publisher",
      "first-page": "384",
      "journal-title": "Nature",
      "key": "1803_CR66",
      "unstructured": "Hsu TY-T, Simon LM, Neill NJ et al (2015) The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature 525:384–388. doi: 10.1038/nature14985",
      "volume": "525",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S1097-2765(03)00089-3",
      "author": "Y Huang",
      "doi-asserted-by": "publisher",
      "first-page": "837",
      "journal-title": "Mol Cell",
      "key": "1803_CR67",
      "unstructured": "Huang Y, Gattoni R, Stévenin J, Steitz JA (2003) SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol Cell 11:837–843. doi: 10.1016/S1097-2765(03)00089-3",
      "volume": "11",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.1119908109",
      "author": "T Ishimoto",
      "doi-asserted-by": "publisher",
      "first-page": "4320",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR68",
      "unstructured": "Ishimoto T, Lanaspa MA, Le MT et al (2012) Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci 109:4320–4325. doi: 10.1073/pnas.1119908109",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.semcdb.2015.08.004",
      "author": "WJ Israelsen",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "journal-title": "Semin Cell Dev Biol",
      "key": "1803_CR69",
      "unstructured": "Israelsen WJ, Vander Heiden MG (2015) Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol 43:43–51. doi: 10.1016/j.semcdb.2015.08.004",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2013.09.025",
      "author": "WJ Israelsen",
      "doi-asserted-by": "publisher",
      "first-page": "397",
      "journal-title": "Cell",
      "key": "1803_CR70",
      "unstructured": "Israelsen WJ, Dayton TL, Davidson SM et al (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155:397–409. doi: 10.1016/j.cell.2013.09.025",
      "volume": "155",
      "year": "2013"
    },
    {
      "DOI": "10.1074/jbc.M109.026237",
      "author": "SW Jang",
      "doi-asserted-by": "publisher",
      "first-page": "24512",
      "journal-title": "J Biol Chem",
      "key": "1803_CR71",
      "unstructured": "Jang SW, Liu X, Fu H et al (2009) Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem 284:24512–24525. doi: 10.1074/jbc.M109.026237",
      "volume": "284",
      "year": "2009"
    },
    {
      "DOI": "10.7150/ijbs.6.806",
      "author": "R Jia",
      "doi-asserted-by": "publisher",
      "first-page": "806",
      "journal-title": "Int J Biol Sci",
      "key": "1803_CR72",
      "unstructured": "Jia R, Li C, McCoy JP et al (2010) SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci 6:806–826. doi: 10.7150/ijbs.6.806",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1210/en.2008-0818",
      "author": "K Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "2087",
      "journal-title": "Endocrinology",
      "key": "1803_CR73",
      "unstructured": "Jiang K, Patel NA, Watson JE et al (2009) Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCβII messenger ribonucleic acid. Endocrinology 150:2087–2097. doi: 10.1210/en.2008-0818",
      "volume": "150",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng.3414",
      "author": "H Jung",
      "doi-asserted-by": "publisher",
      "first-page": "1242",
      "journal-title": "Nat Genet",
      "key": "1803_CR74",
      "unstructured": "Jung H, Lee D, Lee J et al (2015) Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat Genet 47:1242–1248. doi: 10.1038/ng.3414",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S0969-2126(98)00021-5",
      "author": "MS Jurica",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Structure",
      "key": "1803_CR75",
      "unstructured": "Jurica MS, Mesecar A, Heath PJ et al (1998) The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure 6:195–210. doi: 10.1016/S0969-2126(98)00021-5",
      "volume": "6",
      "year": "1998"
    },
    {
      "DOI": "10.1038/nchembio.2007.18",
      "author": "D Kaida",
      "doi-asserted-by": "publisher",
      "first-page": "576",
      "journal-title": "Nat Chem Biol",
      "key": "1803_CR76",
      "unstructured": "Kaida D, Motoyoshi H, Tashiro E et al (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 3:576–583. doi: 10.1038/nchembio.2007.18",
      "volume": "3",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nsmb1209",
      "author": "R Karni",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Nat Struct Mol Biol",
      "key": "1803_CR77",
      "unstructured": "Karni R, de Stanchina E, Lowe SW et al (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14:185–193. doi: 10.1038/nsmb1209",
      "volume": "14",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.0801376105",
      "author": "R Karni",
      "doi-asserted-by": "publisher",
      "first-page": "15323",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR78",
      "unstructured": "Karni R, Hippo Y, Lowe SW, Krainer AR (2008) The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc Natl Acad Sci 105:15323–15327. doi: 10.1073/pnas.0801376105",
      "volume": "105",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.ccell.2015.04.006",
      "author": "E Kim",
      "doi-asserted-by": "publisher",
      "first-page": "617",
      "journal-title": "Cancer Cell",
      "key": "1803_CR79",
      "unstructured": "Kim E, Ilagan JO, Liang Y et al (2015) SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 27:617–630. doi: 10.1016/j.ccell.2015.04.006",
      "volume": "27",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature14351",
      "author": "CM Koh",
      "doi-asserted-by": "publisher",
      "first-page": "96",
      "journal-title": "Nature",
      "key": "1803_CR80",
      "unstructured": "Koh CM, Bezzi M, Low DHP et al (2015) MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature 523:96–100. doi: 10.1038/nature14351",
      "volume": "523",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrd3625",
      "author": "R Kole",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "Nat Rev Drug Discov",
      "key": "1803_CR81",
      "unstructured": "Kole R, Krainer AR, Altman S (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11:125–140. doi: 10.1038/nrd3625",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1038/emm.2006.66",
      "author": "J-H Lee",
      "doi-asserted-by": "publisher",
      "first-page": "565",
      "journal-title": "Exp Mol Med",
      "key": "1803_CR82",
      "unstructured": "Lee J-H, Gao CF, Lee CC et al (2006) An alternatively spliced form of Met receptor is tumorigenic. Exp Mol Med 38:565–573. doi: 10.1038/emm.2006.66",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nm.4097",
      "author": "SC-W Lee",
      "doi-asserted-by": "publisher",
      "first-page": "672",
      "journal-title": "Nat Med",
      "key": "1803_CR83",
      "unstructured": "Lee SC-W, Dvinge H, Kim E et al (2016) Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med 22:672–678. doi: 10.1038/nm.4097",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1038/emboj.2011.259",
      "author": "CV LeFave",
      "doi-asserted-by": "publisher",
      "first-page": "4084",
      "journal-title": "EMBO J",
      "key": "1803_CR84",
      "unstructured": "LeFave CV, Squatrito M, Vorlova S et al (2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. EMBO J 30:4084–4097. doi: 10.1038/emboj.2011.259",
      "volume": "30",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.molcel.2017.02.017",
      "author": "I Legnini",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Cell",
      "key": "1803_CR183",
      "unstructured": "Legnini I, Di Timoteo G, Rossi F et al (2017) Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. doi: 10.1016/j.molcel.2017.02.017",
      "year": "2017"
    },
    {
      "DOI": "10.1038/cr.2015.82",
      "author": "Y Li",
      "doi-asserted-by": "publisher",
      "first-page": "981",
      "journal-title": "Cell Res",
      "key": "1803_CR85",
      "unstructured": "Li Y, Zheng Q, Bao C et al (2015a) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25:981–984. doi: 10.1038/cr.2015.82",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nsmb.2959",
      "author": "Z Li",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "journal-title": "Nat Struct Mol Biol",
      "key": "1803_CR86",
      "unstructured": "Li Z, Huang C, Bao C et al (2015b) Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol 22:256–264. doi: 10.1038/nsmb.2959",
      "volume": "22",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ncb3338",
      "author": "X Li",
      "doi-asserted-by": "publisher",
      "first-page": "561",
      "journal-title": "Nat Cell Biol",
      "key": "1803_CR87",
      "unstructured": "Li X, Qian X, Peng L-X et al (2016) A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation. Nat Cell Biol 18:561–571. doi: 10.1038/ncb3338",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nrgastro.2010.41",
      "author": "JS Lim",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "journal-title": "Nat Rev Gastroenterol Hepatol",
      "key": "1803_CR88",
      "unstructured": "Lim JS, Mietus-Snyder M, Valente A et al (2010) The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7:251–264. doi: 10.1038/nrgastro.2010.41",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cell.2012.08.026",
      "author": "CY Lin",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "Cell",
      "key": "1803_CR89",
      "unstructured": "Lin CY, Lovén J, Rahl PB et al (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56–67. doi: 10.1016/j.cell.2012.08.026",
      "volume": "151",
      "year": "2012"
    },
    {
      "DOI": "10.1038/83762",
      "author": "HX Liu",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Nat Genet",
      "key": "1803_CR90",
      "unstructured": "Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55–58. doi: 10.1038/83762",
      "volume": "27",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.cell.2011.03.054",
      "author": "W Luo",
      "doi-asserted-by": "publisher",
      "first-page": "732",
      "journal-title": "Cell",
      "key": "1803_CR91",
      "unstructured": "Luo W, Hu H, Chang R et al (2011) Pyruvate kinase M2 Is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145:732–744. doi: 10.1016/j.cell.2011.03.054",
      "volume": "145",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrm2672",
      "author": "XM Ma",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "1803_CR92",
      "unstructured": "Ma XM, Blenis J (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10:307–318. doi: 10.1038/nrm2672",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.celrep.2014.03.041",
      "author": "A Maimon",
      "doi-asserted-by": "publisher",
      "first-page": "501",
      "journal-title": "Cell Rep",
      "key": "1803_CR93",
      "unstructured": "Maimon A, Mogilevsky M, Shilo A et al (2014) Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation. Cell Rep 7:501–513. doi: 10.1016/j.celrep.2014.03.041",
      "volume": "7",
      "year": "2014"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-16-1508",
      "author": "P Malakar",
      "doi-asserted-by": "publisher",
      "first-page": "1155",
      "journal-title": "Cancer Res",
      "key": "1803_CR94",
      "unstructured": "Malakar P, Shilo A, Mogilevsky A et al (2017) Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation. Cancer Res 77:1155–1167. doi: 10.1158/0008-5472.CAN-16-1508",
      "volume": "77",
      "year": "2017"
    },
    {
      "DOI": "10.1182/blood-2015-03-633537",
      "author": "L Malcovati",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "Blood",
      "key": "1803_CR95",
      "unstructured": "Malcovati L, Karimi M, Papaemmanuil E et al (2015) SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 126:233–241. doi: 10.1182/blood-2015-03-633537",
      "volume": "126",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature13261",
      "author": "CP Masamha",
      "doi-asserted-by": "publisher",
      "first-page": "412",
      "journal-title": "Nature",
      "key": "1803_CR96",
      "unstructured": "Masamha CP, Xia Z, Yang J et al (2014) CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 509:412–416. doi: 10.1038/nature13261",
      "volume": "509",
      "year": "2014"
    },
    {
      "DOI": "10.1261/rna.055939.116",
      "author": "CP Masamha",
      "doi-asserted-by": "publisher",
      "first-page": "830",
      "journal-title": "RNA",
      "key": "1803_CR97",
      "unstructured": "Masamha CP, Xia Z, Peart N et al (2016) CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function. RNA 22:830–838. doi: 10.1261/rna.055939.116",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.7554/eLife.02028",
      "author": "MM Maslon",
      "doi-asserted-by": "publisher",
      "first-page": "e02028",
      "journal-title": "Elife",
      "key": "1803_CR98",
      "unstructured": "Maslon MM, Heras SR, Bellora N et al (2014) The translational landscape of the splicing factor SRSF1 and its role in mitosis. Elife 3:e02028. doi: 10.7554/eLife.02028",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature01153",
      "author": "N Matter",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Nature",
      "key": "1803_CR99",
      "unstructured": "Matter N, Herrlich P, König H (2002) Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420:691–695. doi: 10.1038/nature01153",
      "volume": "420",
      "year": "2002"
    },
    {
      "DOI": "10.1016/0092-8674(92)90477-T",
      "author": "A Mayeda",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "journal-title": "Cell",
      "key": "1803_CR100",
      "unstructured": "Mayeda A, Krainer AR (1992) Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68:365–375. doi: 10.1016/0092-8674(92)90477-T",
      "volume": "68",
      "year": "1992"
    },
    {
      "DOI": "10.1086/301768",
      "author": "S Mazoyer",
      "doi-asserted-by": "publisher",
      "first-page": "713",
      "journal-title": "Am J Hum Genet",
      "key": "1803_CR101",
      "unstructured": "Mazoyer S, Puget N, Perrin-Vidoz L et al (1998) A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet 62:713–715. doi: 10.1086/301768",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.molcel.2008.03.013",
      "author": "G Michlewski",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Mol Cell",
      "key": "1803_CR102",
      "unstructured": "Michlewski G, Sanford JR, Cáceres JF (2008) The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. Mol Cell 30:179–189. doi: 10.1016/j.molcel.2008.03.013",
      "volume": "30",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nature14508",
      "author": "P Mirtschink",
      "doi-asserted-by": "publisher",
      "first-page": "444",
      "journal-title": "Nature",
      "key": "1803_CR103",
      "unstructured": "Mirtschink P, Krishnan J, Grimm F et al (2015) HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature 522:444–449. doi: 10.1038/nature14508",
      "volume": "522",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S0021-9258(20)82128-0",
      "author": "RW Moreadith",
      "doi-asserted-by": "crossref",
      "first-page": "6215",
      "journal-title": "J Biol Chem",
      "key": "1803_CR104",
      "unstructured": "Moreadith RW, Lehninger AL (1984) The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J Biol Chem 259:6215–6221",
      "volume": "259",
      "year": "1984"
    },
    {
      "DOI": "10.1016/S0021-9258(19)50423-9",
      "author": "T Murakami",
      "doi-asserted-by": "crossref",
      "first-page": "9300",
      "journal-title": "J Biol Chem",
      "key": "1803_CR105",
      "unstructured": "Murakami T, Nishiyama T, Shirotani T et al (1992) Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J Biol Chem 267:9300–9306",
      "volume": "267",
      "year": "1992"
    },
    {
      "DOI": "10.7164/antibiotics.49.1204",
      "author": "H Nakajima",
      "doi-asserted-by": "publisher",
      "first-page": "1204",
      "journal-title": "J Antibiot (Tokyo)",
      "key": "1803_CR106",
      "unstructured": "Nakajima H, Hori Y, Terano H et al (1996) New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J Antibiot (Tokyo) 49:1204–1211. doi: 10.7164/antibiotics.49.1204",
      "volume": "49",
      "year": "1996"
    },
    {
      "DOI": "10.1016/j.molcel.2005.08.025",
      "author": "JCK Ngo",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Mol Cell",
      "key": "1803_CR107",
      "unstructured": "Ngo JCK, Chakrabarti S, Ding JH et al (2005) Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol Cell 20:77–89. doi: 10.1016/j.molcel.2005.08.025",
      "volume": "20",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0021-9258(18)67091-7",
      "author": "T Noguchi",
      "doi-asserted-by": "crossref",
      "first-page": "13807",
      "journal-title": "J Biol Chem",
      "key": "1803_CR108",
      "unstructured": "Noguchi T, Inoue H, Tanaka T (1986) The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261:13807–13812",
      "volume": "261",
      "year": "1986"
    },
    {
      "DOI": "10.1016/j.ccell.2016.08.006",
      "author": "EA Obeng",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "journal-title": "Cancer Cell",
      "key": "1803_CR109",
      "unstructured": "Obeng EA, Chappell RJ, Seiler M et al (2016) Physiologic expression of Sf3b1K700E causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell 30:404–417. doi: 10.1016/j.ccell.2016.08.006",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1021/cb500697f",
      "author": "K Ohe",
      "doi-asserted-by": "publisher",
      "first-page": "914",
      "journal-title": "ACS Chem Biol",
      "key": "1803_CR110",
      "unstructured": "Ohe K, Hagiwara M (2015) Modulation of alternative splicing with chemical compounds in new therapeutics for human diseases. ACS Chem Biol 10:914–924. doi: 10.1021/cb500697f",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.259",
      "author": "Q Pan",
      "doi-asserted-by": "publisher",
      "first-page": "1413",
      "journal-title": "Nat Genet",
      "key": "1803_CR111",
      "unstructured": "Pan Q, Shai O, Lee LJ et al (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413–1415. doi: 10.1038/ng.259",
      "volume": "40",
      "year": "2008"
    },
    {
      "DOI": "10.1074/jbc.M109.056085",
      "author": "G Panasyuk",
      "doi-asserted-by": "publisher",
      "first-page": "30807",
      "journal-title": "J Biol Chem",
      "key": "1803_CR112",
      "unstructured": "Panasyuk G, Nemazanyy I, Zhyvoloup A et al (2009) mTORbeta splicing isoform promotes cell proliferation and tumorigenesis. J Biol Chem 284:30807–30814. doi: 10.1074/jbc.M109.056085",
      "volume": "284",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.tibs.2014.06.005",
      "author": "KC Patra",
      "doi-asserted-by": "publisher",
      "first-page": "347",
      "journal-title": "Trends Biochem Sci",
      "key": "1803_CR113",
      "unstructured": "Patra KC, Hay N (2014) The pentose phosphate pathway and cancer. Trends Biochem Sci 39:347–354. doi: 10.1016/j.tibs.2014.06.005",
      "volume": "39",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.cmet.2015.12.006",
      "author": "NN Pavlova",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "Cell Metab",
      "key": "1803_CR114",
      "unstructured": "Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27–47. doi: 10.1016/j.cmet.2015.12.006",
      "volume": "23",
      "year": "2016"
    },
    {
      "DOI": "10.1101/cshperspect.a008052",
      "author": "P Polakis",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "1803_CR115",
      "unstructured": "Polakis P (2012) Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4:9. doi: 10.1101/cshperspect.a008052",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.3892/ijo.2012.1474",
      "author": "N Popescu",
      "doi-asserted-by": "publisher",
      "first-page": "393",
      "journal-title": "Int J Oncol",
      "key": "1803_CR116",
      "unstructured": "Popescu N (2012) Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (Review). Int J Oncol 41:393–406. doi: 10.3892/ijo.2012.1474",
      "volume": "41",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature10662",
      "author": "PI Poulikakos",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Nature",
      "key": "1803_CR117",
      "unstructured": "Poulikakos PI, Persaud Y, Janakiraman M et al (2011) RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480:387–390. doi: 10.1038/nature10662",
      "volume": "480",
      "year": "2011"
    },
    {
      "DOI": "10.1128/MCB.23.20.7315-7328.2003",
      "author": "JC Rathmell",
      "doi-asserted-by": "publisher",
      "first-page": "7315",
      "journal-title": "Mol Cell Biol",
      "key": "1803_CR118",
      "unstructured": "Rathmell JC, Fox CJ, Plas DR et al (2003) Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23:7315–7328. doi: 10.1128/MCB.23.20.7315-7328.2003",
      "volume": "23",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-10-4447",
      "author": "J Rauch",
      "doi-asserted-by": "publisher",
      "first-page": "4664",
      "journal-title": "Cancer Res",
      "key": "1803_CR119",
      "unstructured": "Rauch J, Moran-Jones K, Albrecht V et al (2011) c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway. Cancer Res 71:4664–4674. doi: 10.1158/0008-5472.CAN-10-4447",
      "volume": "71",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.molcel.2016.01.015",
      "author": "RS Redis",
      "doi-asserted-by": "publisher",
      "first-page": "520",
      "journal-title": "Mol Cell",
      "key": "1803_CR120",
      "unstructured": "Redis RS, Vela LE, Lu W et al (2016) Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell 61:520–534. doi: 10.1016/j.molcel.2016.01.015",
      "volume": "61",
      "year": "2016"
    },
    {
      "DOI": "10.2967/jnumed.106.037291",
      "author": "CC Riedl",
      "doi-asserted-by": "publisher",
      "first-page": "771",
      "journal-title": "J Nucl Med",
      "key": "1803_CR121",
      "unstructured": "Riedl CC, Akhurst T, Larson S et al (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. J Nucl Med 48:771–775. doi: 10.2967/jnumed.106.037291",
      "volume": "48",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nrc.2016.89",
      "author": "F Röhrig",
      "doi-asserted-by": "publisher",
      "first-page": "732",
      "journal-title": "Nat Rev Cancer",
      "key": "1803_CR122",
      "unstructured": "Röhrig F, Schulze A (2016) The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer 16:732–749. doi: 10.1038/nrc.2016.89",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gkq494",
      "author": "GA Roybal",
      "doi-asserted-by": "publisher",
      "first-page": "6664",
      "journal-title": "Nucleic Acids Res",
      "key": "1803_CR123",
      "unstructured": "Roybal GA, Jurica MS (2010) Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation. Nucleic Acids Res 38:6664–6672. doi: 10.1093/nar/gkq494",
      "volume": "38",
      "year": "2010"
    },
    {
      "author": "AL Rubin",
      "first-page": "2832",
      "journal-title": "Cancer Res",
      "key": "1803_CR124",
      "unstructured": "Rubin AL (1990) Suppression of transformation by and growth adaptation to low concentrations of glutamine in NIH-3T3 Cells. Cancer Res 50:2832–2839",
      "volume": "50",
      "year": "1990"
    },
    {
      "DOI": "10.7164/antibiotics.55.855",
      "author": "Y Sakai",
      "doi-asserted-by": "publisher",
      "first-page": "855",
      "journal-title": "J Antibiot (Tokyo)",
      "key": "1803_CR125",
      "unstructured": "Sakai Y, Yoshida T, Ochiai K et al (2002) GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp. I. Taxonomy, production, isolation, physicochemical properties and biological activities. J Antibiot (Tokyo) 55:855–862. doi: 10.7164/antibiotics.55.855",
      "volume": "55",
      "year": "2002"
    },
    {
      "DOI": "10.7164/antibiotics.57.180",
      "author": "T Sakai",
      "doi-asserted-by": "publisher",
      "first-page": "180",
      "journal-title": "J Antibiot (Tokyo)",
      "key": "1803_CR126",
      "unstructured": "Sakai T, Asai N, Okuda A et al (2004) Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) 57:180–187. doi: 10.7164/antibiotics.57.180",
      "volume": "57",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1155390",
      "author": "R Sandberg",
      "doi-asserted-by": "publisher",
      "first-page": "1643",
      "journal-title": "Science",
      "key": "1803_CR127",
      "unstructured": "Sandberg R, Neilson JR, Sarma A et al (2008) Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer MicroRNA target sites. Science 320:1643–1647. doi: 10.1126/science.1155390",
      "volume": "320",
      "year": "2008"
    },
    {
      "DOI": "10.1101/gad.286404",
      "author": "JR Sanford",
      "doi-asserted-by": "publisher",
      "first-page": "755",
      "journal-title": "Genes Dev",
      "key": "1803_CR128",
      "unstructured": "Sanford JR, Gray NK, Beckmann K, Cáceres JF (2004) A novel role for shuttling SR proteins in mRNA translation. Genes Dev 18:755–768. doi: 10.1101/gad.286404",
      "volume": "18",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-2564",
      "author": "DJ Sanz",
      "doi-asserted-by": "publisher",
      "first-page": "1957",
      "journal-title": "Clin Cancer Res",
      "key": "1803_CR129",
      "unstructured": "Sanz DJ, Acedo A, Infante M et al (2010) A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin Cancer Res 16:1957–1967. doi: 10.1158/1078-0432.CCR-09-2564",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature11706",
      "author": "A Schulze",
      "doi-asserted-by": "publisher",
      "first-page": "364",
      "journal-title": "Nature",
      "key": "1803_CR130",
      "unstructured": "Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491:364–373. doi: 10.1038/nature11706",
      "volume": "491",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrg.2015.3",
      "author": "MM Scotti",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "Nat Rev Genet",
      "key": "1803_CR131",
      "unstructured": "Scotti MM, Swanson MS (2016) RNA mis-splicing in disease. Nat Rev Genet 17:19–32. doi: 10.1038/nrg.2015.3",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S0021-9258(18)55132-2",
      "author": "RA Shapiro",
      "doi-asserted-by": "crossref",
      "first-page": "18792",
      "journal-title": "J Biol Chem",
      "key": "1803_CR132",
      "unstructured": "Shapiro RA, Farrell L, Srinivasan M, Curthoys NP (1991) Isolation, characterization, and in vitro expression of a cDNA that encodes the kidney isoenzyme of the mitochondrial glutaminase. J Biol Chem 266:18792–18796",
      "volume": "266",
      "year": "1991"
    },
    {
      "DOI": "10.4161/23723548.2014.970955",
      "author": "A Shilo",
      "doi-asserted-by": "publisher",
      "first-page": "e970955",
      "journal-title": "Mol Cell Oncol",
      "key": "1803_CR133",
      "unstructured": "Shilo A, Siegfried Z, Karni R (2015) The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression. Mol Cell Oncol 2:e970955. doi: 10.4161/23723548.2014.970955",
      "volume": "2",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrm3757",
      "author": "M Shimobayashi",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "1803_CR134",
      "unstructured": "Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15:155–162. doi: 10.1038/nrm3757",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ccell.2015.04.008",
      "author": "CL Shirai",
      "doi-asserted-by": "publisher",
      "first-page": "631",
      "journal-title": "Cancer Cell",
      "key": "1803_CR135",
      "unstructured": "Shirai CL, Ley JN, White BS et al (2015) Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo. Cancer Cell 27:631–643. doi: 10.1016/j.ccell.2015.04.008",
      "volume": "27",
      "year": "2015"
    },
    {
      "DOI": "10.1155/2013/568931",
      "author": "Z Siegfried",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Int J Cell Biol",
      "key": "1803_CR136",
      "unstructured": "Siegfried Z, Bonomi S, Ghigna C, Karni R (2013) Regulation of the Ras-MAPK and PI3K-mTOR signalling pathways by alternative splicing in cancer. Int J Cell Biol 2013:1–9. doi: 10.1155/2013/568931",
      "volume": "2013",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0134882",
      "author": "RP Siqueira",
      "doi-asserted-by": "publisher",
      "first-page": "e0134882",
      "journal-title": "PLoS ONE",
      "key": "1803_CR137",
      "unstructured": "Siqueira RP, de Barbosa ÉAA, Polêto MD et al (2015) Potential antileukemia effect and structural analyses of SRPK Inhibition by N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl)isonicotinamide (SRPIN340). PLoS ONE 10:e0134882. doi: 10.1371/journal.pone.0134882",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature12040",
      "author": "J Son",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Nature",
      "key": "1803_CR138",
      "unstructured": "Son J, Lyssiotis CA, Ying H et al (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:101–105. doi: 10.1038/nature12040",
      "volume": "496",
      "year": "2013"
    },
    {
      "DOI": "10.1182/blood-2008-08-173799",
      "author": "M Stark",
      "doi-asserted-by": "publisher",
      "first-page": "4362",
      "journal-title": "Blood",
      "key": "1803_CR139",
      "unstructured": "Stark M, Wichman C, Avivi I, Assaraf YG (2009) Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia. Blood 113:4362–4369. doi: 10.1182/blood-2008-08-173799",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ccell.2015.09.016",
      "author": "ZE Stine",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Cancer Cell",
      "key": "1803_CR140",
      "unstructured": "Stine ZE, Dang CV (2015) Splicing and dicing MYC-mediated synthetic lethality. Cancer Cell 28:405–406. doi: 10.1016/j.ccell.2015.09.016",
      "volume": "28",
      "year": "2015"
    },
    {
      "DOI": "10.1046/j.1523-1755.1999.055003778.x",
      "author": "M Stumvoll",
      "doi-asserted-by": "publisher",
      "first-page": "778",
      "journal-title": "Kidney Int",
      "key": "1803_CR141",
      "unstructured": "Stumvoll M, Perriello G, Meyer C, Gerich J (1999) Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int 55:778–792. doi: 10.1046/j.1523-1755.1999.055003778.x",
      "volume": "55",
      "year": "1999"
    },
    {
      "DOI": "10.1073/pnas.87.21.8602",
      "author": "N Sugawa",
      "doi-asserted-by": "publisher",
      "first-page": "8602",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR142",
      "unstructured": "Sugawa N, Ekstrand AJ, James CD, Collins VP (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci 87:8602–8606. doi: 10.1073/pnas.87.21.8602",
      "volume": "87",
      "year": "1990"
    },
    {
      "DOI": "10.1242/dev.129676",
      "author": "N Sultana",
      "doi-asserted-by": "publisher",
      "first-page": "1547",
      "journal-title": "Development",
      "key": "1803_CR143",
      "unstructured": "Sultana N, Dienes B, Benedetti A et al (2016) Restricting calcium currents is required for correct fiber type specification in skeletal muscle. Development 143:1547–1559. doi: 10.1242/dev.129676",
      "volume": "143",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.neulet.2004.10.051",
      "author": "M Szeliga",
      "doi-asserted-by": "publisher",
      "first-page": "171",
      "journal-title": "Neurosci Lett",
      "key": "1803_CR144",
      "unstructured": "Szeliga M, Sidoryk M, Matyja E et al (2005) Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci Lett 374:171–173. doi: 10.1016/j.neulet.2004.10.051",
      "volume": "374",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s11064-007-9507-6",
      "author": "M Szeliga",
      "doi-asserted-by": "publisher",
      "first-page": "808",
      "journal-title": "Neurochem Res",
      "key": "1803_CR145",
      "unstructured": "Szeliga M, Matyja E, Obara M et al (2008) Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors. Neurochem Res 33:808–813. doi: 10.1007/s11064-007-9507-6",
      "volume": "33",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1432-1033.1996.00366.x",
      "author": "M Takenaka",
      "doi-asserted-by": "crossref",
      "first-page": "366",
      "journal-title": "Eur J Biochem",
      "key": "1803_CR146",
      "unstructured": "Takenaka M, Yamada K, Lu T et al (1996) Alternative splicing of the pyruvate kinase M gene in a minigene system. Eur J Biochem 235:366–371",
      "volume": "235",
      "year": "1996"
    },
    {
      "DOI": "10.1016/j.bbadis.2008.09.017",
      "author": "J Tazi",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "journal-title": "Biochim Biophys Acta Mol Basis Dis",
      "key": "1803_CR147",
      "unstructured": "Tazi J, Bakkour N, Stamm S (2009) Alternative splicing and disease. Biochim Biophys Acta Mol Basis Dis 1792:14–26. doi: 10.1016/j.bbadis.2008.09.017",
      "volume": "1792",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0108",
      "author": "Z Tiran",
      "doi-asserted-by": "publisher",
      "first-page": "4612",
      "journal-title": "Clin Cancer Res",
      "key": "1803_CR148",
      "unstructured": "Tiran Z, Oren A, Hermesh C et al (2008) A novel recombinant soluble splice variant of met is a potent antagonist of the hepatocyte growth factor/scatter factor-met pathway. Clin Cancer Res 14:4612–4621. doi: 10.1158/1078-0432.CCR-08-0108",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1126/science.aaf2397",
      "author": "L Traunmüller",
      "doi-asserted-by": "publisher",
      "first-page": "982",
      "journal-title": "Science",
      "key": "1803_CR149",
      "unstructured": "Traunmüller L, Gomez AM, Nguyen T-M, Scheiffele P (2016) Control of neuronal synapse specification by a highly dedicated alternative splicing program. Science 352:982–986. doi: 10.1126/science.aaf2397",
      "volume": "352",
      "year": "2016"
    },
    {
      "DOI": "10.1042/BJ20021360",
      "author": "A Turner",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "journal-title": "Biochem J",
      "key": "1803_CR150",
      "unstructured": "Turner A, McGivan JD (2003) Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J 370:403–408. doi: 10.1042/BJ20021360",
      "volume": "370",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrd3504",
      "author": "MG Vander Heiden",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "journal-title": "Nat Rev Drug Discov",
      "key": "1803_CR151",
      "unstructured": "Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10:671–684. doi: 10.1038/nrd3504",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-1910",
      "author": "JP Venables",
      "doi-asserted-by": "crossref",
      "first-page": "7647",
      "journal-title": "Cancer Res",
      "key": "1803_CR152",
      "unstructured": "Venables JP (2004) Aberrant and alternative splicing in cancer. Cancer Res 64:7647–7654",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.cell.2014.09.005",
      "author": "Q Vicens",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Cell",
      "key": "1803_CR153",
      "unstructured": "Vicens Q, Westhof E (2014) Biogenesis of circular RNAs. Cell 159:13–14. doi: 10.1016/j.cell.2014.09.005",
      "volume": "159",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nm1087",
      "author": "B Vogelstein",
      "doi-asserted-by": "publisher",
      "first-page": "789",
      "journal-title": "Nat Med",
      "key": "1803_CR154",
      "unstructured": "Vogelstein B, Kinzler K (2004) Cancer genes and the pathways they control. Nat Med 10:789–799. doi: 10.1038/nm1087",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.molcel.2011.08.009",
      "author": "S Vorlová",
      "doi-asserted-by": "publisher",
      "first-page": "927",
      "journal-title": "Mol Cell",
      "key": "1803_CR155",
      "unstructured": "Vorlová S, Rocco G, LeFave CV et al (2011) Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic PolyA activation. Mol Cell 43:927–939. doi: 10.1016/j.molcel.2011.08.009",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrg2164",
      "author": "G-S Wang",
      "doi-asserted-by": "publisher",
      "first-page": "749",
      "journal-title": "Nat Rev Genet",
      "key": "1803_CR156",
      "unstructured": "Wang G-S, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8:749–761. doi: 10.1038/nrg2164",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nature07509",
      "author": "ET Wang",
      "doi-asserted-by": "publisher",
      "first-page": "470",
      "journal-title": "Nature",
      "key": "1803_CR157",
      "unstructured": "Wang ET, Sandberg R, Luo S et al (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476. doi: 10.1038/nature07509",
      "volume": "456",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.ccr.2010.08.009",
      "author": "JB Wang",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Cancer Cell",
      "key": "1803_CR158",
      "unstructured": "Wang JB, Erickson JW, Fuji R et al (2010) Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18:207–219. doi: 10.1016/j.ccr.2010.08.009",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1593/neo.101744",
      "author": "H Wang",
      "doi-asserted-by": "publisher",
      "first-page": "461",
      "journal-title": "Neoplasia",
      "key": "1803_CR159",
      "unstructured": "Wang H, Zhou M, Shi B et al (2011) Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity. Neoplasia 13:461–471. doi: 10.1593/neo.101744",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1098/rsob.120133",
      "author": "Z Wang",
      "doi-asserted-by": "publisher",
      "first-page": "120133",
      "journal-title": "Open Biol",
      "key": "1803_CR160",
      "unstructured": "Wang Z, Jeon HY, Rigo F et al (2012) Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides. Open Biol 2:120133. doi: 10.1098/rsob.120133",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cell.2014.07.048",
      "author": "Y-H Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1309",
      "journal-title": "Cell",
      "key": "1803_CR161",
      "unstructured": "Wang Y-H, Israelsen WJ, Lee D et al (2014) Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell 158:1309–1323. doi: 10.1016/j.cell.2014.07.048",
      "volume": "158",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12943-017-0598-7",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "journal-title": "Mol Cancer",
      "key": "1803_CR162",
      "unstructured": "Wang Y, Mo Y, Gong Z et al (2017) Circular RNAs in human cancer. Mol Cancer 16:25. doi: 10.1186/s12943-017-0598-7",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1126/science.123.3191.309",
      "author": "O Warburg",
      "doi-asserted-by": "publisher",
      "first-page": "309",
      "journal-title": "Science",
      "key": "1803_CR163",
      "unstructured": "Warburg O (1956) On the origin of cancer cells. Science 123:309–314. doi: 10.1126/science.123.3191.309",
      "volume": "123",
      "year": "1956"
    },
    {
      "DOI": "10.1097/00000441-193107000-00022",
      "author": "O Warburg",
      "doi-asserted-by": "publisher",
      "first-page": "519",
      "journal-title": "J Gen Physiol",
      "key": "1803_CR164",
      "unstructured": "Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530. doi: 10.1097/00000441-193107000-00022",
      "volume": "8",
      "year": "1927"
    },
    {
      "DOI": "10.1016/j.ccr.2012.02.014",
      "author": "PS Ward",
      "doi-asserted-by": "publisher",
      "first-page": "297",
      "journal-title": "Cancer Cell",
      "key": "1803_CR165",
      "unstructured": "Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21:297–308. doi: 10.1016/j.ccr.2012.02.014",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ccr.2010.01.020",
      "author": "PS Ward",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Cancer Cell",
      "key": "1803_CR166",
      "unstructured": "Ward PS, Patel J, Wise DR et al (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:225–234. doi: 10.1016/j.ccr.2010.01.020",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1139/o79-029",
      "author": "T Welbourne",
      "doi-asserted-by": "crossref",
      "first-page": "233",
      "journal-title": "Can J Biochem",
      "key": "1803_CR167",
      "unstructured": "Welbourne T (1979) Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem 53:233–237",
      "volume": "53",
      "year": "1979"
    },
    {
      "DOI": "10.1002/ijc.29919",
      "author": "A Wojtuszkiewicz",
      "doi-asserted-by": "publisher",
      "first-page": "1645",
      "journal-title": "Int J Cancer",
      "key": "1803_CR168",
      "unstructured": "Wojtuszkiewicz A, Raz S, Stark M et al (2016) Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance. Int J Cancer 138:1645–1656. doi: 10.1002/ijc.29919",
      "volume": "138",
      "year": "2016"
    },
    {
      "DOI": "10.1002/(SICI)1098-2264(199702)18:2\u003c102::AID-GCC4\u003e3.0.CO;2-6",
      "author": "CF Xu",
      "doi-asserted-by": "publisher",
      "first-page": "102",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "1803_CR169",
      "unstructured": "Xu CF, Chambers JA, Nicolai H et al (1997) Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer 18:102–110. doi: 10.1002/(SICI)1098-2264(199702)18:2\u003c102:AID-GCC4\u003e3.0.CO;2-6",
      "volume": "18",
      "year": "1997"
    },
    {
      "DOI": "10.1093/nar/gkf492",
      "author": "Q Xu",
      "doi-asserted-by": "publisher",
      "first-page": "3754",
      "journal-title": "Nucleic Acids Res",
      "key": "1803_CR170",
      "unstructured": "Xu Q, Modrek B, Lee C (2002) Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 30:3754–3766. doi: 10.1093/nar/gkf492",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1101/gad.241968.114",
      "author": "Y Xu",
      "doi-asserted-by": "publisher",
      "first-page": "1191",
      "journal-title": "Genes Dev",
      "key": "1803_CR171",
      "unstructured": "Xu Y, Gao XD, Lee J-H et al (2014) Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing. Genes Dev 28:1191–1203. doi: 10.1101/gad.241968.114",
      "volume": "28",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrc.2016.81",
      "author": "M Yang",
      "doi-asserted-by": "publisher",
      "first-page": "650",
      "journal-title": "Nat Rev Cancer",
      "key": "1803_CR172",
      "unstructured": "Yang M, Vousden KH (2016) Serine and one-carbon metabolism in cancer. Nat Rev Cancer 16:650–662. doi: 10.1038/nrc.2016.81",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature10598",
      "author": "W Yang",
      "doi-asserted-by": "publisher",
      "first-page": "118",
      "journal-title": "Nature",
      "key": "1803_CR173",
      "unstructured": "Yang W, Xia Y, Ji H et al (2011) Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 478:118–122. doi: 10.1038/nature10598",
      "volume": "478",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.1204176109",
      "author": "J Ye",
      "doi-asserted-by": "publisher",
      "first-page": "6904",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR174",
      "unstructured": "Ye J, Mancuso A, Tong X et al (2012) Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci 109:6904–6909. doi: 10.1073/pnas.1204176109",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature10496",
      "author": "K Yoshida",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "journal-title": "Nature",
      "key": "1803_CR175",
      "unstructured": "Yoshida K, Sanada M, Shiraishi Y et al (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64–69. doi: 10.1038/nature10496",
      "volume": "478",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1088753",
      "author": "X Yu",
      "doi-asserted-by": "publisher",
      "first-page": "639",
      "journal-title": "Science",
      "key": "1803_CR176",
      "unstructured": "Yu X, Chini CCS, He M et al (2003) The BRCT domain is a phospho-protein binding domain. Science 302:639–642. doi: 10.1126/science.1088753",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1038/onc.2008.245",
      "author": "TL Yuan",
      "doi-asserted-by": "publisher",
      "first-page": "5497",
      "journal-title": "Oncogene",
      "key": "1803_CR177",
      "unstructured": "Yuan TL, Cantley LC (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27:5497–5510. doi: 10.1038/onc.2008.245",
      "volume": "27",
      "year": "2008"
    },
    {
      "DOI": "10.1083/jcb.200703099",
      "author": "M Yuneva",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "J Cell Biol",
      "key": "1803_CR178",
      "unstructured": "Yuneva M, Zamboni N, Oefner P et al (2007) Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178:93–105. doi: 10.1083/jcb.200703099",
      "volume": "178",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.93.5.1847",
      "author": "SP Zamora-León",
      "doi-asserted-by": "publisher",
      "first-page": "1847",
      "journal-title": "Proc Natl Acad Sci",
      "key": "1803_CR179",
      "unstructured": "Zamora-León SP, Golde DW, Concha II et al (1996) Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci 93:1847–1852. doi: 10.1073/pnas.93.5.1847",
      "volume": "93",
      "year": "1996"
    },
    {
      "DOI": "10.1016/j.molcel.2004.10.031",
      "author": "Z Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "597",
      "journal-title": "Mol Cell",
      "key": "1803_CR180",
      "unstructured": "Zhang Z, Krainer AR (2004) Involvement of SR proteins in mRNA surveillance. Mol Cell 16:597–607. doi: 10.1016/j.molcel.2004.10.031",
      "volume": "16",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.canlet.2015.11.045",
      "author": "S Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "journal-title": "Cancer Lett",
      "key": "1803_CR181",
      "unstructured": "Zhang S, Wei JS, Li SQ et al (2016) MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma. Cancer Lett 371:214–224. doi: 10.1016/j.canlet.2015.11.045",
      "volume": "371",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.molcel.2012.05.014",
      "author": "Z Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "422",
      "journal-title": "Mol Cell",
      "key": "1803_CR182",
      "unstructured": "Zhou Z, Qiu J, Liu W et al (2012) The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol Cell 47:422–433. doi: 10.1016/j.molcel.2012.05.014",
      "volume": "47",
      "year": "2012"
    }
  ],
  "reference-count": 183,
  "references-count": 183,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-017-1803-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The role of RNA alternative splicing in regulating cancer metabolism"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "136"
}